A Guide for Selection, Sequencing, and Optimal Use of HER2-Targeted Therapies in HER2+ Breast Cancer
1:03:59
Selecting and Sequencing of HER2-Targeting Therapies in HER2-Positive Metastatic Breast Cancer
58:27
Addressing Key Targets in Advanced NSCLC: HER2-, HER3-, and TROP2-Targeted Therapies
1:27:23
Shifting to Higher Standards in MDS
1:04:29
Debate Anthracyclines…To give or not to give
54:43
The Science of HER2-low Breast Cancer and Implications for the Pathology Team
49:04
Advancing Therapeutic Control in Desmoid Tumors
7:44
Treatment Options for HER2+ Breast Cancer: A Comprehensive Guide
1:55:18